Skip to main content
logo
Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
11.89
+0.18 (1.54%)
Aug 21, 2026, 3:50 PM EDT - Market open

Kura Oncology Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
77.2367.4853.88---
Revenue Growth
-7.27%25.24%----
Gross Profit
-182.81-183.65-116.08-115.24-92.81-
Operating Income
-318.09-303.63-193.2-165.8-139.87-131.26
Net Income
-296.78-278.67-173.98-152.63-135.84-130.47
Earnings Per Share
-3.36-3.18-2.02-2.08-2.03-1.97
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
519.03667.24727.4423.96437.99517.96
Total Debt
24.4620.4616.5917.214.026.88
Net Cash (Debt)
494.57646.78710.8406.76423.96511.09
Net Cash Growth
-19.09%-9.01%74.75%-4.06%-17.05%-17.35%
Net Cash Per Share
5.607.388.255.556.337.70

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-111.76-64.06134.32-124.82-110.06-104.55
Capital Expenditures
-5.67-6.64-0.47-0.17-0.63-1.15
Free Cash Flow
-117.43-70.7133.85-124.99-110.69-105.7
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-236.72%-272.14%-215.44%---
Operating Margin
-411.90%-449.94%-358.54%---
Pretax Margin
-384.19%-412.51%-319.15%---
Profit Margin
-384.30%-412.95%-322.89%---
FCF Margin
-152.06%-104.76%248.40%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
--5.06---
PS Ratio
13.8913.4012.57---